1. , , , et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30: 119–41.
2. , , . Sedating critically ill patients: factors affecting nurses' delivery of sedative therapy. Am J Crit Care 2001; 10: 156–65.
3. , . Epidemiology of sedation and sedation adequacy for mechanically ventilated patients in a medical and surgical intensive care unit. Crit Care Med 2007; 35: 393–401.
4. , , , et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology 2007; 106: 687–95.
5. , , , et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006; 34: 374–80.
6. , , . Sedation and analgesia in the intensive care unit. Am J Respir Crit Care Med 2002; 166: 1024–8.
7. , . Sedation in the intensive care unit. Curr Opin Crit Care 2002; 8: 290–8.
8. , . Post-ICU consequences of patient wakefulness and sedative exposure during mechanical ventilation. Intensive Care Med 2008; 34: 82–90
9. , , , et al. Patients' recollections of stressful experiences while receiving prolonged mechanical ventilation in an intensive care unit. Crit Care Med 2002; 30: 746–52.
10. , , . Disturbed memory and amnesia related to intensive care. Memory 2000; 8: 79–94.
11. , , , . Memory, delusions, and the development of acute posttraumatic stress disorder-related symptoms after intensive care. Crit Care Med 2001; 29: 573–80.
12. , , , et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008; 65: 34–41.
13. , , , et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286: 2703–10.
14. . Neurologic Complications of Critical Illness, 2nd edn. New York, NY: Oxford University Press, 2002.
15. , , , et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104: 21–6.
16. , . Alcohol abuse in the critically ill patient. Lancet 2006; 368: 2231–42.
17. , , , et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 2003; 58: 76–81.
18. , , , et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994; 272: 1518–22.
19. , , , et al. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 1998; 114: 541–8.
20. , , , . Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471–7.
21. , , , , . Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Crit Care Med 2000; 28: 3626–30.
22. , , . Cognitive sequelae in acute respiratory distress syndrome patients with and without recall of the intensive care unit. J Int Neuropsychol Soc 2007; 13: 595–605.
23. , , , , . Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001; 27: 1297–304.
24. , , , . A comparison of hypnotic and analgesic based sedation in a general intensive care unit. Br J Anaesth 2007; 98: 76–82.
25. , . Pharmacology and pharmacokinetics of sedatives and analgesics. Gastrointest Endosc Clin N Am 2004; 14: 247–68.
26. , , , . A myoclonic reaction with low-dose hydromorphone. Ann Pharmacother 2006; 40: 2068–70.
27. , , , et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care 2004; 8: R268–80.
28. , . Remifentanil: a review of its analgesic and sedative use in the intensive care unit. Drugs 2006; 66: 365–85.
29. , , , et al. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology 1995; 83: 968–75.
30. , , , et al. Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment. Crit Care 2004; 8: R21–30.
31. , , , et al. Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment. Br J Anaesth 2004; 92: 493–503.
32. , , , . Sedation in the intensive care unit. Crit Care Med 2000; 28: 854–66.
33. , . Benzodiazepines in the intensive care unit. Crit Care Clin 2001; 17: 843–62.
34. , , . Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit. Crit Care Clinics 2001; 17: 863–80.
35. . Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units. Clin Ther 1997; 19: 405–19.
36. , , , et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis. Gut 1986; 27: 190–5.
37. , . Use of midazolam hydrochloride in anesthesia. Clin Pharm 1987; 6: 533–47.
38. , , , , . The pharmacokinetics of midazolam in chronic renal failure patients. Anesthesiology 1983; 59: 390–4.
39. , , . The effects of acute changes in renal function on the pharmacokinetics of midazolam during long-term infusion in ICU patients. Acta Anaesthesiol Belg 1991; 42: 149–55.
40. , , , et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61: 27–35.
41. , , , . Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 1992; 20: 1123–6.
42. . Propofol: a new drug for sedation in the intensive care unit. Int Anesthesiol Clin 1995; 33: 131–54.
43. , , , et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998; 87: 695–700.
44. , , . Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients. Intensive Care Med 1993; 19: 299–302.
45. , , , , . Propofol in anesthesia. Mechanism of action, structure–activity relationships, and drug delivery. Curr Med Chem 2000; 7: 249–71.
46. , , , et al. Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001; 95: 324–33.
47. , , . Vascular effects of propofol: smooth muscle relaxation in isolated veins and arteries. J Pharm Pharmacol 1989; 41: 797–8.
48. , , , . The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 2003; 29: 1417–25.
49. , , . New agents for sedation in the intensive care unit. Crit Care Clin 2001; 17: 881–97.
50. , , , . The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg 2001; 92: 1251–3.
51. , , , et al. Dexmedetomidine for awake carotid endarterectomy: efficacy, hemodynamic profile, and side effects. J Neurosurg Anesthesiol 2004; 16: 126–35.
52. , , , et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298: 2644–53.
53. , , , . Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 2001; 86: 650–6.
54. , , , , . Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32: 1322–6.
55. , , , et al. The α2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98: 428–36.
56. , , , . Dexmedetomodine is neuroprotective against wortmannin and staurosporine-induced apoptosis in vitro. ASA Abstract 2004; A778.
57. , , , et al. Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 2002; 96: 450–7.
58. , , , . Controlled sedation with alphaxalone-alphadolone. Br Med J 1974; 2: 656–9.
59. , , . Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1999; 27: 1325–9.
60. , , , et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289: 2983–91.
61. , , , et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166: 1338–44.
62. , . An introduction to bispectral analysis for the electroencehpalogram. J Clin Monit 1994; 10: 392–404.
63. , , , et al. Presence of 14Hz spindle oscillations in the human EEG during deep anesthesia. Clin Neurophysiol 2006; 117: 157–68.
64. , , , et al. New approaches for the detection and analysis of electroencephalographic burst-suppression patterns in patients under sedation. J Clin Monit Comput 1999; 15: 357–67.
65. , , , et al. Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ 2002; 324: 1386–9.
66. , , , et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27: 2609–15.
67. , , , et al. Use of continuous bispectral EEG monitoring to assess depth of sedation in ICU patients. Intensive Care Med 1998; 24: 1294–8.
68. , , , et al. Presence of EEG burst suppression in critically ill patients is associated with increased mortality. Crit Care Med 2008; 36: 3171–7.
69. , , , . Assessing sedation during intensive care unit mechanical ventilation with the bispectral index and the sedation-agitation scale. Crit Care Med 1999; 27: 1499–504.
70. , , , . Validating the sedation-agitation scale with the bispectral index and visual analog scale in adult ICU patients after cardiac surgery. Intensive Care Med 2001; 27: 853–8.
71. , , , . The impact of bispectral index monitoring on sedation administration in mechanically ventilated patients. Anaesth Intensive Care 2007; 35: 204–8.
72. , , , et al. The long-term psychological effects of daily sedative interruption on critically ill patients. Am J Respir Crit Care Med 2003; 168: 1457–61.
73. , , , et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126–34.
74. , , , , . Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology 2004; 101: 640–6.
75. , , , et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]. Crit Care 2004; 8: R1–11.
76. , , , et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care 2005; 9: R200–10.
77. , , , et al. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost. Crit Care Med. 1996; 24: 222–8.
78. , , , , . A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology 2001; 95: 286–98.
79. , , , , . Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison. Crit Care Med 1999; 27: 2454–8.
80. , , , et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med 2006; 34: 1326–32.
81. , , , et al. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 1997; 25: 33–40.
82. , , , et al. Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam. Am J Respir Crit Care Med 1996; 153: 1012–18.
83. , , , et al. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med 1997; 23: 1258–63.
84. , , , et al. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest 2001; 119: 1151–9.
85. , , , , . A lack of evidence of superiority of propofol versus midazolam for sedation in mechanically ventilated critically ill patients: a qualitative and quantitative systematic review. Anesth Analg 2001; 92: 975–83.
86. , . Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth 2001; 87: 684–90.
87. , , . Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4: 302–8.
88. , , . ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimens. J Cardiothorac Vasc Anesth 2003; 17: 576–84.
89. , , , et al. Dexmedetomidine does not improve patient satisfaction when compared with propofol during mechanical ventilation. Crit Care Med 2005; 33: 940–5.
90. , , , et al. Comparison of sedation with dexmedetomidine versus lorazepam in septic ICU patients. Crit Care 2008; 12: P275
91. , , , , . Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med 2001; 27: 859–64.
92. , , , et al. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med 2007; 33: 1007–13.
93. , , , et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340: 669–76.
94. , , , et al. The effects of a targeted multicomponent delirium intervention on postdischarge outcomes for hospitalized older adults. Am J Med 2003; 114: 383–90.
95. , , , . Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc 2001; 49: 516–22.
96. , , , et al. Systematic detection and multidisciplinary care of delirium in older medical inpatients: a randomized trial. CMAJ 2002; 167: 753–9.
97. , , , et al. A nurse-led interdisciplinary intervention program for delirium in elderly hip-fracture patients. J Am Geriatr Soc 2001; 49: 523–32.
98. , , , et al. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc 2005; 53: 622–8.
99. , , , . Use of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot study. Respir Care 2006; 51: 492–6.
100. , , , et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med 2004; 32: 106–12.
101. , , , et al. High levels of dopamine d2 receptor occupancy with low-dose haloperidol treatment: a pet study. Am J Psychiatry 1996; 153: 948–50.
102. , , , . Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med 2004; 30: 444–9.
103. , , , . Aripiprazole in the treatment of delirium. Int J Psychiatry Med 2005; 35: 429–33.
104. , , . Prevention and treatment strategies for delirium. Primary Psychiatry 2004; 11: 52–8.
105. . The role of antipsychotics in treating delirium. Curr Psychiatry Rep 2002; 4: 209–12.
106. , , , et al. Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet 1981; 2: 651–3.
107. , , , et al. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med 2005; 33: 226–9.
108. , , , et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study. J Am Geriatr Soc 2005; 53: 1658–66.
109. , , , et al. Delirium resolving upon switching from risperidone to quetiapine: implication of the CYP2D6 genotype. Psychosomatics 2005; 46: 374–5.
110. , , , et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335–41.
111. , , . Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294: 1934–43.
112. , , . Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293: 596–608.
113. . Management of the difficult adult airway. With special emphasis on awake tracheal intubation. Anesthesiology 1991; 75: 1087–110.
114. , . Airway regional anesthesia for awake fiberoptic intubation. Reg Anesth Pain Med 2002; 27: 180–92.
115. . Fibreoptic intubation. Can J Anaesth 1994; 41: 996–1007.
116. , , , et al. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 2002; 46: 350–4.
117. , , , et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 2003; 97: 904–8.
118. , , , . Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 2008; 100: 125–30.
119. , , , et al. Propofol without muscle relaxants for conventional or fiberoptic nasotracheal intubation: a dose-finding study. Anesth Analg 2000; 91: 458–61.
120. , , , et al. Sedation for fiberoptic bronchoscopy: fewer adverse cardiovascular effects with propofol than with midazolam. Anasthesiol Intensivmed Notfallmed Schmerzther 2004; 39: 597–602.
121. , , , . Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 2007; 19: 370–3.
122. , , , . Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesthesiol 2005; 17: 97–9.
123. , , , et al. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 2007; 19: 141–4.
124. , , . Closed claims review of anesthesia for procedures outside the operating room. Curr Opin Anaesthesiol 2006; 19: 436–42.
125. . The nature of anesthesia and procedural sedation outside of the operating room. Curr Opin Anaesthesiol 2007; 20: 347–51.
126. . Anesthesia and sedation outside the operating room: how to prevent risk and maintain good quality. Curr Opin Anaesthesiol 2007; 20: 513–19.
127. , , . Interventional neuroradiology: anesthetic considerations. Anesthesiol Clin North America 2002; 20: 347–59, vi.
128. . Anesthesia for magnetic resonance imaging. Curr Opin Anaesthesiol 2004; 17: 339–42.
129. , . Anesthesia outside the operating room: general overview and monitoring standards. Int Anesthesiol Clin 2003; 41: 1–15.
130. , , , , . Anaesthetic considerations for interventional neuroradiology. Br J Anaesth 2007; 99: 75–85.
131. , , , . Sevoflurane for interventional neuroradiology procedures is associated with more rapid early recovery than propofol. Can J Anaesth 2004; 51: 486–91.
132. , , , et al. Deep sedation occurs frequently during elective endoscopy with meperidine and midazolam. Am J Gastroenterol 2005; 100: 2689–95.
133. , , , et al. Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists. Gastrointest Endosc 2002; 55: 815–25.
134. , , , . Trained registered nurses/endoscopy teams can administer propofol safely for endoscopy. Gastroenterology 2005; 129: 1384–91.
135. , , , et al. Nurse-administered propofol sedation without anesthesia specialists in 9152 endoscopic cases in an ambulatory surgery center. Am J Gastroenterol 2003; 98: 1744–50.
136. , . Preparation, premedication and surveillance in gastrointestinal endoscopy. Endoscopy 1994; 26: 3–8.
137. , , , et al. Can remifentanil be a better choice than propofol for colonoscopy during monitored anesthesia care? Acta Anaesthesiol Scand 2006; 50: 736–41.
138. , , , et al. Conscious analgesia/sedation with remifentanil and propofol versus total intravenous anesthesia with fentanyl, midazolam, and propofol for outpatient colonoscopy. Gastrointest Endosc 2003; 57: 657–63.
139. , , , et al. Midazolam and pethidine versus propofol and fentanyl patient controlled sedation/analgesia for upper gastrointestinal tract ultrasound endoscopy: a prospective randomized controlled trial. Dig Liver Dis 2007; 39: 1024–9.
140. , , , et al. Target-controlled infusion during monitored anesthesia care in patients undergoing EUS: propofol alone versus midazolam plus propofol. A prospective double-blind randomised controlled trial. Dig Liver Dis 2007; 39: 81–6.
141. , , , et al. Target-controlled propofol infusion during monitored anesthesia in patients undergoing ERCP. Gastrointest Endosc 2004; 60: 361–6.
142. , , , . A randomized, double-blind, placebo-controlled study to evaluate topical anaesthesia of the pharynx in upper gastrointestinal endoscopy. Endoscopy 1992; 24: 585–7.
143. , , , et al. Topical pharyngeal anesthesia improves tolerance of upper gastrointestinal endoscopy: a randomized double-blind study. Endoscopy 1995; 27: 659–64.
144. , , , . Topical pharyngeal anesthesia without intravenous sedation during upper gastrointestinal endoscopy. Indian J Gastroenterol 1997; 16: 10–11.
145. . Morbidity and mortality related to anesthesia outside the operating room. Minerva Anestesiol 2005; 71: 325–34.